Stockreport

Looking At The Narrative For Hikma Pharmaceuticals LSE HIK After Analyst Split On Fair Value [Yahoo! Finance]

HIKMA PHARMS PLC S/ADR  (HKMPY) 
NASDAQ:AMEX Investor Relations: hikma.com/en/investors.html
PDF The latest research includes optimistic calls in the £23.00 to £25.10 range and a more cautious £16.00 target, so the new fair value sits closer to the middle of that sp [Read more]